---
title: "Median Technologies partners with Canon’s Olea Medical to commercialize eyonis LCS lung cancer screening software"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294390643.md"
description: "Median Technologies has entered a global commercialization agreement with Olea Medical, a Canon unit, for its eyonis LCS lung cancer screening AI software. Olea will co-market the product in the US and Europe, leveraging Canon's CT imaging base. The commercial rollout is scheduled after FDA 510(k) clearance in February 2026 and CE marking in July 2026. Median employs a multi-channel strategy including direct sales and partnerships like Tempus AI."
datetime: "2026-07-30T15:53:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294390643.md)
  - [en](https://longbridge.com/en/news/294390643.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294390643.md)
---

# Median Technologies partners with Canon’s Olea Medical to commercialize eyonis LCS lung cancer screening software

-   Median Technologies signed a global commercialization agreement with Olea Medical, a Canon Medical Systems unit, for its eyonis LCS lung cancer screening AI software. \* Olea will co-market the product in the US and Europe, leveraging Canon’s installed base in CT imaging used for lung screening. \* The deal targets commercial rollout following FDA 510(k) clearance in February 2026 and CE marking in July 2026. \* Median is pursuing a multi-channel go-to-market model combining direct sales with non-exclusive distribution partnerships, including an earlier tie-up with Tempus AI. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Median Technologies SA published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CAJPY.US](https://longbridge.com/en/quote/CAJPY.US.md)
- [TEM.US](https://longbridge.com/en/quote/TEM.US.md)
- [TEMT.US](https://longbridge.com/en/quote/TEMT.US.md)
- [7751.JP](https://longbridge.com/en/quote/7751.JP.md)

## Related News & Research

- [Tempus AI CEO and Chairman Eric Lefkofsky disposes of USD 10.75 million in common shares](https://longbridge.com/en/news/294438460.md)
- [Tempus AI Q2 revenue slightly beats estimates](https://longbridge.com/en/news/294409431.md)
- [Meet the Gen Z AI whiz at the center of a hedge fund meltdown](https://longbridge.com/en/news/294425537.md)
- [Quanta Services surges on blowout earnings for AI power infrastructure giant](https://longbridge.com/en/news/294368119.md)
- [Canon says Amazon removes ink cartridge listings over alleged infringement of its U.S. Patent No. 8,152,277](https://longbridge.com/en/news/294281695.md)